Results 11 to 20 of about 372,893 (296)

Cutaneous and Mucocutaneous Leishmaniasis

Actas Dermo-Sifiliográficas (English Edition), 2021
Leishmaniasis is a chronic disease caused by flagellate protozoa of the genus Leishmania. It is a global disease, but most cases are seen in South America, the Mediterranean, and some areas of Asia and Africa. The 3 main types of leishmaniasis are cutaneous (the most common), mucocutaneous, and visceral (the most severe). Visceral leishmaniasis is also
P A Cerro, Yolanda Gilaberte, A M Palma-Ruiz, I Abadías-Granado, A. Diago   +4 more
openaire   +5 more sources

Biomarkers of Cutaneous Leishmaniasis [PDF]

Frontiers in Cellular and Infection Microbiology, 2018
Cutaneous leishmaniasis (CL) is an immune-mediated skin pathology caused mainly by Leishmania (L.) major, Leishmania tropica, Leishmania braziliensis, L. mexicana, and L. amazonensis. The burden of CL in terms of morbidity and social stigmas are concentrated on certain developing countries in Asia, Africa, and South America. People with asymptomatic CL
Bahrami, Fariborz; Harandi, Ali M.; Riafati, Sima   +3 more
openaire   +5 more sources

Complete Resolution of Cutaneous Leishmaniasis With a Novel Topical Combination Therapy: A Case Series. [PDF]

Clin Case Rep
ABSTRACT Cutaneous leishmaniasis (CL) remains a therapeutic challenge in endemic regions, with 600,000–1 million new cases annually facing limited treatment options. We present a case series evaluating an innovative topical combination therapy for acute‐phase CL in Shiraz, Iran.
Haghshenas H, Ghanaatpisheh A, Darayesh M, Entezar Almahdi E.   +3 more
europepmc   +2 more sources

Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments

American Journal of Clinical Dermatology, 2022
This review is an update of an earlier narrative review published in 2015 on developments in the clinical management of cutaneous leishmaniasis (CL) including diagnosis, treatment, prevention and control measurements.
H. D. de Vries, Henk Schallig
semanticscholar   +1 more source

Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)

Frontiers in Cellular and Infection Microbiology, 2021
Leishmaniasis is a neglected tropical disease that affects 12 million people worldwide. The disease has high morbidity and mortality rates and is prevalent in over 80 countries, leaving more than 300 million people at risk of infection.
Greta Volpedo, Thalia Pacheco-Fernández, Erin A. Holcomb, Natalie Cipriano, B. Cox, A. Satoskar   +5 more
semanticscholar   +1 more source

Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review

PLoS Neglected Tropical Diseases, 2021
Cutaneous leishmaniasis has been endemic since decades. Millions of cases are reported worldwide specially in developing and underdeveloped countries. There are 2 major types of cutaneous leishmaniasis based on the causating species found in different ...
M. Azim, S. Khan, Saleem Ullah, Shafiq Ullah, Syed Ishtiaq Anjum   +4 more
semanticscholar   +1 more source

Host-Directed Therapies for Cutaneous Leishmaniasis

Frontiers in Immunology, 2021
Cutaneous leishmaniasis exhibits a wide spectrum of clinical presentations from self-resolving infections to severe chronic disease. Anti-parasitic drugs are often ineffective in the most severe forms of the disease, and in some cases the magnitude of ...
F. Novais, C. Amorim, P. Scott
semanticscholar   +1 more source

The Sociodemographic Risk Factors Associated With Cutaneous Leishmaniasis of the Hazara Community of Quetta, Balochistan, Pakistan: A Cross-Sectional Study. [PDF]

Health Sci Rep
ABSTRACT Background/Aim Cutaneous leishmaniasis (CL) is a protozoan disease transmitted by sandflies, causing skin lesions and scars. In Pakistan, the Hazara community in Balochistan is significantly affected, with over 400,000 cases reported in 2016.
Ali Z, Khan MH, Akbar A, Bahar T, Ali H, Shoaib F, Shah A, Singh AK.   +7 more
europepmc   +2 more sources

The Geographical Distribution of Cutaneous Leishmaniasis Causative Agents in Iran and Its Neighboring Countries, A Review

Frontiers in Public Health, 2020
Leishmania tropica and Leishmania major are both the main cause of anthroponotic (ACL) and zoonotic cutaneous leishmaniasis (ZCL), respectively, in the Old World.
M. A. Ghatee, W. Taylor, M. Karamian
semanticscholar   +1 more source

Systemic Treatments of Leishmaniasis: A Narrative Review [PDF]

Reviews in Clinical Medicine, 2019
Cutaneous leishmaniasis is a prevalent parasitic infection in humans. According to the reports published in several localities across the world, leishmaniasis is an endemic disease in certain regions in Iran.
Ahmad Reza Taheri, Sara Sabouri Rad, Sara Molkara   +2 more
doaj   +1 more source